coronary heart disease
Conditions
Interventions
Normal blood flow group (TIMI blood flow is class 3):N/A
Abnormal blood flow group (TIMI blood flow =2):N/A
Sponsors
Department of Cardiology,Heji Hospital Affiliated to Changzhi Medical College
Eligibility
Sex/Gender
All
Age
27 Years to 87 Years
Inclusion criteria
Inclusion criteria: Select STEMI patients admitted to the affiliated Heji Hospital of Changzhi Medical College and the affiliated Heping Hospital of Changzhi Medical College between July 2021 and September 2022 who experienced slow blood flow or no reflow that met diagnostic criteria.
Exclusion criteria
Exclusion criteria: (1) patients did not receive PCI for the first time; (2) intravenous thrombolytic therapy within 24 hours before operation; (3) patients with a recent (3 months) history of severe organ failure, major operation, or hemorrhage; (4) structural heart disease; (5) abnormal immune system or malignant tumor; (6) patients whose vital signs could not support the end of the operation. (7) the patient's family members explicitly refused PCI treatment or chose coronary artery bypass grafting and signed the consent form; (8) the clinical data were incomplete.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| platelet to lymphocyte ratio;CHA2DS2-VASc score;HAKTT score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Age;Gender;History of smoking;History of hypertension;History of diabetes;Triglyceride; | — |
Countries
China
Contacts
Public ContactXiaojian Liu
Heji Hospital Affiliated to Changzhi Medical College
Outcome results
None listed